VIICTR Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Methylene Blue for Vasoplegic Syndrome After Cardiac Operation: Early Administration Improves Survival.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Methylene Blue for Vasoplegic Syndrome After Cardiac Operation: Early Administration Improves Survival.
Methylene Blue for Vasoplegic Syndrome After Cardiac Operation: Early Administration Improves Survival. Ann Thorac Surg. 2017 Jul; 104(1):36-41.
View in:
PubMed
subject areas
Aged
Cardiac Surgical Procedures
Enzyme Inhibitors
Female
Humans
Male
Methylene Blue
Middle Aged
Postoperative Care
Postoperative Complications
Retrospective Studies
Risk Factors
Survival Rate
Treatment Outcome
Vasoplegia
Virginia
authors with profiles
RAVI GHANTA